Elevation of tumor necrosis factor-α, interleukin-1β and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes

Chinese Medical Journal

Volumn 120, Issue 6, 2007, Pages 479-484

  Lu, Lin ^a   Zhang, Qi ^a   Pu, Li Jin ^a   Xu, Xue Wei ^a   Zhang, Rui Yan ^a   Zhang, Jian Sheng ^a   Hu, Jian ^a   Yang, Zheng Kun ^a   Lü, An Kang ^a   Ding, Feng Hua ^a   Shen, Jie ^a   Chen, Qiu Jin ^a   Lou, Sheng ^a   Fang, Dan Hong ^a   Shen, Wei Feng ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Interleukin 1 ; Interleukin 6; Streptozotocin; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CREATININE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; MESSENGER RNA; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA INTIMA; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; MALE; MINIPIG; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

EID: 34047184770     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200703020-00009     Document Type: Article

References (20)

1. Li CJ, Gao RL, Yang YJ, Chen JL, Qin XW, Xu B, et al. The influence of diabetes mellitus on the procedural and in-hospital outcomes after elective percutaneous coronary intervention. Chin Med J 2005; 118: 1220-1224.
2. Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 2002; 1: 1.
3. Martens FM, Rabelink TJ, op't Roodt J, de Koning EJ, Visseren FL. TNF-alpha induces endothelial dysfunction in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. Eur Heart J 2006; 27: 1605-1609.
4. Lim HS, Blann AD, Lip GY. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 2004; 109: 2524-2528.
5. Vassiliadis S, Dragiotis V, Protopapadakis E, Athanassakis I, Mitlianga P, Konidaris K, et al. The destructive action of IL-1alpha and IL-1beta in IDDM is a multistage process: evidence and confirmation by apoptotic studies, induction of intermediates and electron microscopy. Mediators Inflam 1999; 8: 85-91.
6. Zhou YS, Gao Y, Guo XH, Li B, Wang S, Chi JM. Effects of timely insulin treatment on protection of β cells in a rat model of type 2 diabetes mellitus. Chin Med J 2004; 117: 1523-1529.
7. Liao N, Xie ZF, Zhao H, Shi HZ. Effects of streptozotocin diabetes on antigen-induced airway inflammation. Chin Med J 2006; 119: 226-229.
8. Stump KC, Swindle MM, Saudek CD, Strandberg JD. Pancreatectomized swine as a model of diabetes mellitus. Lab Anim Sci 1988; 38: 439-443.
9. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 1999; 19: 2981-2992.
10. Larsen MO, Wilken M, Gotfredsen CF, Carr RD, Svendsen O, Rolin B. Mild streptozotocin diabetes in the Gottingen minipig. A novel model of moderate insulin deficiency and diabetes. Am J Physiol Endocrinol Metab 2002; 282: E1342-E1351.
11. Larsen MO, Rolin B. Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 2004; 45: 303-313.
12. Wang Z, Gleichmann H. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low-doses of streptozotocin in mice. Diabetes 1998; 47: 50-56.
13. Zahner D, Malaisse WJ. Kinetic behavior of liver glucokinase in diabetes. I. Alternation in streptozotocin-diabetic rats. Diabetes Res 1990; 14: 101-108.
14. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002; 512: 121-134.
15. Gabel H, Bitter-Suermann H, Henriksson C, Save-Soderbergh J, Lundholm K, Brynger H. Streptozotocin diabetes in juvenile pigs. Evaluation of an experimental model. Horm Metab Res 1985; 17: 275-280.
16. Grussner R, Nakhleh R, Grussner A, Tomadze G, Diem P, Sutherland D. Streptozotocin-induced diabetes mellitus in pigs. Horm Metab Res 1993; 25: 199-203.
17. Larson MO, Juhl CB, Porkson N, Gotfredsen CF, Carr RD, Ribel U, et al. β-cell function and islet morphology in normal, obese, and obese β-cell mass-reduced Gottingen minipigs. Am J Physiol Endocrinol Metab 2005; 288: E412-E421.
18. Hill BJ, Dixon JL, Sturek M. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 2001; 159: 117-124.
19. American Diabetes Association. Consensus statement: role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diabetes Care 1993; 6: 72-78.
20. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-214.